Schizophrenia.com

AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia

everhopeful September 4, 2024, 8:57pm 1

1 Like

Topic		Replies	Views	Activity
AbbVie Announces Provincial Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia in Québec Medications	1	293	April 17, 2023
FDA Approves VRAYLAR as Adjunctive Therapy for Major Depressive Disorder and AbbVie Announces Reimbursement Program in Canada Medications	0	227	June 7, 2023
When will Vraylar become available in Canada? DX'd - Other	13	750	November 17, 2020
New AP med, Cariprazine , gets FDA approval News	0	689	September 29, 2015
Whats the difference between Abilify and Vraylar? DX'd - Other	6	381	April 4, 2022